Cost-Effective Engineering Strategies to Improve 3D Bioprinting: Practical Modifications and Smart Technological Horizons

3D bioprinting has evolved from developing simple cellular constructs to fabricating intricate, physiologically relevant tissue models. However, translation is bottlenecked by high equipment costs and processing trade-offs. This narrative review evaluates cost-effective engineering strategies over the past five years designed to enhance printing fidelity independently of material-chemistry innovations. Our observation reveals that thermal stabilization (2–60 °C) and static mixing elements yield resolutions down to 15 µm from cell-friendly 1 mm nozzles, while automated nozzle arrays accelerate spheroid processing 10 times. In-flow microfluidic gelation and self-healing granular baths eliminate architectural collapse, successfully preserving blood-vessel lumens (~50 µm). Additionally, newly developed procedural strategies significantly optimize output: nozzle-free painting and delayed-mixing droplet collision bypass clogging limits to handle ultra-dense networks, while vat-free projection methods reduce bioink waste to under 1%. These affordable modifications consistently preserve high post-printing cell viability (>90%) across complex, heterogeneous configurations. Ultimately, we conclude that the future of biofabrication relies on a transition toward closed-loop, AI-driven parameter optimization and the systematic integration of bioprinting platforms with active bioreactors to guide early structural constructs into functional, mature tissues.